MXCT vs NIO · rev $38.6M vs rev $12.51B
MaxCyte Inc (MXCT) versus Nio Inc Class A ADR (NIO) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
Nio Inc Class A ADR (NIO) is a auto manufacturers company listed on US.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported NIO revenue for 2025-12-31 was $12.51B. Net income was -$2.14B. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. NIO currently screens at market cap $7.61B.
MXCT currently screens at market cap $124.3M. NIO currently screens at market cap $7.61B.
Not investment advice. Open the MXCT and NIO stock pages for the full models.
Not investment advice.